Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Peritoneal Neoplasms × Pemetrexed × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 590 Lung Neoplasms 187 Neoplasms 66 Neoplasm Metastasis 45 Mesothelioma, Malignant 45 Adenocarcinoma of Lung 41 Mesothelioma 39 Colorectal Neoplasms 28 Breast Neoplasms 23 Carcinoma 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 21 Meningeal Carcinomatosis 19 Head and Neck Neoplasms 19 Brain Neoplasms 18 Ovarian Neoplasms 17 Adenocarcinoma 15 Small Cell Lung Carcinoma 14 NSCLC 14 Melanoma 12 Squamous Cell Carcinoma of Head and Neck 11 Recurrence 11 Pancreatic Neoplasms 11 Lung Diseases 10 Carcinoma, Transitional Cell 10 Uterine Cervical Neoplasms 9 Neoplasms by Site 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Thoracic Neoplasms 8 Non-squamous Non-small Cell Lung Cancer 8 Carcinoma, Bronchogenic 8

Interventions

Paclitaxel 24 Hyperthermic Intraperitoneal Chemotherapy 24 Cisplatin 22 Oxaliplatin 17 Carboplatin 17 Fluorouracil 13 Cytoreduction Surgical Procedures 13 Bevacizumab 10 Mitomycin 9 Leucovorin 8 Doxorubicin 8 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Neoadjuvant Therapy 3 Drug Therapy 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 epothilone B 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03875144 2026-02-09

MESOTIP

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Suspended

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡